PT  - JOURNAL ARTICLE
AU  - Roach, P
AU  - Zwiers, A
AU  - Cox, E
AU  - Fischer, K
AU  - Charlton, A
AU  - Josephson, CB
AU  - Patten, SB
AU  - Seitz, D
AU  - Ismail, Z
AU  - Smith, EE
AU  - ,
TI  - Understanding the impact of the COVID-19 pandemic on well-being and virtual care for people living with dementia and care partners living in the community
AID  - 10.1101/2020.06.04.20122192
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.04.20122192
4099  - http://medrxiv.org/content/early/2020/06/05/2020.06.04.20122192.short
4100  - http://medrxiv.org/content/early/2020/06/05/2020.06.04.20122192.full
AB  - The COVID-19 pandemic has necessitated public health measures that have impacted the provision of care for people living with dementia and their families. Additionally, the isolation that results from social distancing may be harming well-being for families, as formal and informal supports become less accessible. For those with living with dementia and experiencing agitation, social distancing may be even harder to maintain, or social distancing could potentially aggravate dementia-related neuropsychiatric symptoms. To understand the lived experience of social and physical distancing during the COVID-19 pandemic in Canada we remotely interviewed 21 participants who normally attend a dementia specialty clinic in Calgary, Alberta, during a period where essential businesses were closed and healthcare had abruptly transitioned to telemedicine. The impacts of the public health measures in response to the pandemic emerged in three main categories of experience: 1) personal; 2) health services; and 3) health status (of both person living with dementia and care partner). This in-depth understanding of the needs and experiences of the pandemic for people living with dementia suggests that innovative means are urgently needed to facilitate provision of remote medicine and also social interaction and integration.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/A - not a clinical trialFunding StatementThis work is supported by an award from the University of Calgary Cumming School of Medicine COVID Rapid Response Clinical Research Fund (Grant number: CRF-COVID-202003). Direct and in-kind funding was also provided by the Brain and Mental Health Research Clinics, a part of Hotchkiss Brain Institute (https://brainandmentalhealthclinics.ca/). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Conjoint Human Research Ethics Board at the University of Calgary (REB20-0559).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesQualitative interview data is available as provided in manuscript